Home > Insider Trading > Filing (0001736297-24-000029)

Filing Details

Accession Number:: 0001736297-24-000029
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-09-04 16:07:17
Reporting Period:: 2024-08-30

Accepted Time:: 2024-09-04 16:07:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1736297	Astera Labs Inc.	ALAB	Semiconductors & Related Devices (3674)	823437062

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1998179	Sanjay Gajendra	C/O Astera Labs, Inc. 2901 Tasman Drive, Suite 205 Santa Clara CA 95054	See Remarks	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-08-30	20,888	$41.45	7,084,657	No	4	S	Indirect	By Trust 1
Common Stock	Disposition	2024-08-30	20,472	$42.24	7,064,185	No	4	S	Indirect	By Trust 1
Common Stock	Disposition	2024-08-30	7,237	$43.12	7,056,948	No	4	S	Indirect	By Trust 1
Common Stock	Disposition	2024-08-30	3,803	$44.21	7,053,145	No	4	S	Indirect	By Trust 1
Common Stock	Disposition	2024-08-30	6,499	$45.03	7,046,646	No	4	S	Indirect	By Trust 1
Common Stock	Disposition	2024-08-30	2,200	$46.11	7,044,446	No	4	S	Indirect	By Trust 1
Common Stock	Disposition	2024-08-30	600	$47.85	7,043,846	No	4	S	Indirect	By Trust 1
Common Stock	Disposition	2024-08-30	5,400	$45.08	869,600	No	4	S	Indirect	By Trust 2
Common Stock	Disposition	2024-08-30	300	$46.16	869,300	No	4	S	Indirect	By Trust 2
Common Stock	Disposition	2024-08-30	100	$47.85	869,200	No	4	S	Indirect	By Trust 2
Common Stock	Disposition	2024-08-30	5,400	$45.05	869,600	No	4	S	Indirect	By Trust 3
Common Stock	Disposition	2024-08-30	300	$46.16	869,300	No	4	S	Indirect	By Trust 3
Common Stock	Disposition	2024-08-30	100	$47.85	869,200	No	4	S	Indirect	By Trust 3

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Trust 1
No	4	S	Indirect	By Trust 1
No	4	S	Indirect	By Trust 1
No	4	S	Indirect	By Trust 1
No	4	S	Indirect	By Trust 1
No	4	S	Indirect	By Trust 1
No	4	S	Indirect	By Trust 1
No	4	S	Indirect	By Trust 2
No	4	S	Indirect	By Trust 2
No	4	S	Indirect	By Trust 2
No	4	S	Indirect	By Trust 3
No	4	S	Indirect	By Trust 3
No	4	S	Indirect	By Trust 3

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,704,335	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 31, 2024.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.79 to $41.78. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 3 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.79 to $42.78. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.79 to $43.77. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.79 to $44.73. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.80 to $45.40. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.84 to $46.77. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.89. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 3 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.13 to $46.21. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
These shares represent an award of restricted stock units ("RSUs") granted on January 24, 2024 under the Astera Labs, Inc. Amended and Restated 2018 Equity Incentive Plan, all of which RSUs are currently unvested. Such award vests upon satisfaction of both (i) a time-based condition, which provides that the RSUs shall vest as to 25% on February 15, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter, and (ii) a performance-based condition, which is satisfied upon the occurrence of a change in control of the Issuer or the consummation of an initial public offering of the Issuer's equity securities, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.